Did you know that robotic assistance can eliminate hand tremor during prostate surgery, potentially improving precision in delicate areas near the urinary sphincter? Robotic HoLEP (Holmium Laser Enucleation of the Prostate) combines holmium laser technology with robotic assistance to remove enlarged prostate tissue blocking urine flow. During this procedure, the surgeon removes the entire transitional zone of the prostate, the area that grows and causes urinary symptoms, while preserving the outer capsule.
Unlike TURP (which removes tissue in small pieces), HoLEP removes the obstructing tissue in large sections. This can allow removal regardless of prostate size.
The robotic enhancement provides stability during the surgeon’s movements. This can be beneficial for larger prostates or complex anatomies.
How Robotic HoLEP Works
The procedure uses a holmium laser (a type of surgical laser) delivered through a flexible fibre to separate the enlarged prostate tissue from its capsule (the outer layer of the prostate). The surgeon creates a plane between the adenoma (the enlarged tissue) and the surgical capsule. This is similar to removing the fruit from inside an orange while leaving the peel intact.
The robotic platform stabilises the endoscope (a thin tube with a camera) and laser fibre. This eliminates hand tremor and allows tissue dissection. Once the tissue is freed into the bladder, a morcellator, a device with rotating blades that cuts the tissue into small fragments for removal, is used. The entire procedure occurs through the urethra (the tube that carries urine out of the body) without external incisions.
The holmium laser wavelength strongly absorbs in tissue water. This creates a cutting effect with minimal thermal spread, meaning it doesn’t heat surrounding areas. This helps reduce damage to surrounding structures. These include the urinary sphincter (the muscle that controls urine flow) and neurovascular bundles (nerves and blood vessels) responsible for continence and sexual function.
Robotic HoLEP Procedure Characteristics
Robotic HoLEP removes prostate tissue through the urethra using laser technology, while TURP removes prostate tissue through the urethra using an electrical loop. The laser seals blood vessels as it cuts, potentially reducing bleeding. Patients may be able to continue blood thinners through the procedure, which can help maintain stroke prevention therapy.
The procedure can be performed on prostates of various sizes. TURP may become more challenging with larger prostates, while HoLEP can be performed on larger prostates as well. The tissue removal approach may affect retreatment considerations.
Hospital stays may be shorter than open surgery. Some patients may return home the same day with the catheter (a thin tube that drains urine from the bladder), which is typically removed within a day. The robotic enhancement provides visualisation and control, particularly at the apex where the prostate meets the external sphincter (the muscle that controls urine flow). A healthcare professional can discuss the potential benefits and risks of this procedure.
The Surgical Procedure
Pre-operative Preparation
Patients undergo cystoscopy to evaluate the urethra and bladder anatomy. A cystoscopy is a procedure in which a thin camera is inserted through the urethra to examine the bladder and the urinary tract. Urine culture confirms the absence of infection. The surgical team reviews PSA levels and any previous prostate biopsies to plan the approach. PSA is a protein produced by the prostate that can indicate prostate health. Patients receive spinal or general anaesthesia based on medical conditions and preferences.
Surgical Steps
The surgeon inserts the resectoscope through the urethra and examines the prostatic urethra, verumontanum, and bladder neck. A resectoscope is an instrument with a camera and surgical tools used to perform the procedure. Using the holmium laser, the surgeon makes circumferential incisions at the bladder neck to define the dissection plane. If present, the median lobe is enucleated first, followed by the lateral lobes. Enucleation means the tissue is separated and removed from the surrounding tissue.
The robotic system maintains steady positioning while the surgeon develops the plane between the adenoma and capsule. The adenoma is the enlarged prostate tissue. The capsule is the outer layer of the prostate. The surgeon systematically frees the tissue using a combination of blunt dissection and laser cutting. The surgeon seals blood vessels as they are encountered. Once completely freed, the enlarged prostate tissue is pushed into the bladder.
The surgeon introduces the morcellator to fragment and evacuate the tissue. A morcellator is a device that cuts tissue into small pieces. The surgeon inspects the prostatic fossa for bleeding points and achieves haemostasis. The prostatic fossa is the space where the prostate tissue was removed. Haemostasis means stopping any bleeding. The surgeon places a three-way catheter for continuous bladder irrigation overnight.
Post-operative Protocol
Continuous bladder irrigation runs overnight to prevent clot formation. The following morning, irrigation stops. The catheter may be removed after a voiding trial that confirms the patient can urinate normally. Patients learn pelvic floor exercises to support continence recovery. The surgical team sends tissue specimens to a pathologist for examination to rule out cancer.
Recovery Timeline and Expectations
Most patients experience improvement in urinary flow after catheter removal. Blood-tinged urine persists for two to four weeks as the surgical cavity heals. Urinary frequency (needing to urinate often) and urgency (feeling a sudden, strong need to urinate) are commonly seen initially. The bladder adjusts to improved emptying during this time.
Week 1-2: Light activities resume. Patients avoid straining, heavy lifting, and prolonged sitting. Urinary symptoms fluctuate as inflammation resolves. Retrograde ejaculation (when semen enters the bladder instead of exiting through the penis during orgasm) becomes apparent in sexually active patients.
Week 3-4: Patients return to normal activities, including exercise. Urinary control improves. Energy levels normalise. The prostatic fossa (the space left after prostate tissue removal) continues healing. Re-epithelialisation (regrowth of the tissue lining) begins.
Week 6-8: The prostatic cavity heals. Urinary symptoms stabilise at their improved baseline. Sexual function can return to pre-operative levels, though retrograde ejaculation persists in many patients.
Month 3-6: Patients can achieve symptom improvement. The prostatic fossa re-epithelialises. PSA levels (a protein produced by the prostate, measured to monitor prostate health) decrease substantially due to adenoma removal. This establishes a new baseline for cancer screening.
Candidate Selection Criteria
Ideal candidates have moderate to severe lower urinary tract symptoms (such as frequent urination, weak urine stream, or difficulty emptying the bladder completely) that are unresponsive to medical therapy. The International Prostate Symptom Score (IPSS), a questionnaire that measures the severity of urinary symptoms, typically exceeds a certain threshold. Urodynamics (specialised tests that measure how well the bladder and urethra store and release urine) may confirm bladder outlet obstruction in complex cases.
Prostate size does not limit candidacy. HoLEP treats prostates of varying sizes. Patients on anticoagulation (blood-thinning medication) can undergo the procedure without medication interruption. Those with bladder stones have simultaneous stone fragmentation (breaking up stones into smaller pieces) during the procedure.
Poor candidates include:
- Those with untreated urinary tract infections
- Suspected prostate cancer requiring staging
- Severe bladder dysfunction
- Smaller prostates may benefit more from alternative procedures
- Patients unable to tolerate the lithotomy position (lying on their back with legs raised and supported) for extended periods need careful evaluation
Previous prostate surgery, urethral strictures (narrowing of the urethra), or bladder neck contractures (tightening of the bladder neck) require additional planning but don’t preclude treatment. The surgeon modifies the technique based on altered anatomy while achieving the enucleation goals.
💡 Did You Know?
The holmium laser can also fragment bladder stones (break up mineral deposits that have formed in the bladder) during the procedure, eliminating the need for separate surgeries. The laser allows selective stone destruction without damaging the bladder wall.
Potential Risks and Complications
Temporary urinary incontinence (difficulty controlling urination) affects some patients, particularly those with pre-existing bladder dysfunction. Stress incontinence (leaking when coughing, sneezing, or exercising) can often resolve within three months through pelvic floor exercises. Some cases experience persistent incontinence beyond six months.
Retrograde ejaculation occurs in many patients as the bladder neck opens widely after surgery. Semen enters the bladder instead of exiting through the urethra. This results in dry orgasm (orgasm without ejaculation). This doesn’t affect hormone production or orgasm sensation but impacts fertility.
Some patients develop urethral strictures (narrowing of the urethra) or bladder neck contractures (scarring at the bladder outlet). These typically manifest as a gradually worsening stream months after surgery. They can respond to procedures where a healthcare professional gently stretches or makes a small incision in the narrowed area.
Incomplete emptying may persist if the bladder has lost contractility (the ability to squeeze and push out urine) from years of obstruction. Bladder function studies before surgery can help predict this outcome. Some patients require intermittent catheterisation (periodically inserting a thin tube to drain the bladder) or medications to assist emptying.
Long-term Outcomes
Symptom improvement persists over the years with minimal tissue regrowth. Quality of life scores show improvement and remain stable. Maximum flow rates increase from baseline averages to higher post-operative levels.
Retreatment rates remain low due to complete adenoma removal. The remaining peripheral zone can still develop cancer, requiring continued PSA monitoring. The new PSA baseline after surgery is typically lower than pre-operative levels.
Sexual function, aside from ejaculation changes, can return to baseline or improve due to improved overall health and reduced urinary symptoms. Erectile function is preserved as the procedure avoids the neurovascular bundles.
The robotic enhancement may influence these outcomes, though long-term comparative data continue accumulating. Early results suggest reduced catheterisation time and faster continence recovery compared to standard HoLEP.
Preparation Steps for Surgery
- Stop certain medications as directed by your surgeon. This typically includes anti-inflammatory drugs (such as ibuprofen or aspirin) before surgery, while continuing prescribed blood thinners. Your surgeon can provide personalised guidance based on your specific medications and health conditions.
- Complete pre-operative testing. This includes blood work (which checks factors like blood count and clotting ability), ECG (a test that records your heart’s electrical activity), and chest X-ray if indicated. A urine culture, the test that checks for infection in your urine, should show no infection or complete antibiotic treatment first.
- Arrange post-operative support for transportation home and assistance for the first few days. Stock supplies, including stool softeners, pain medication, and comfortable loose clothing.
- Strengthen pelvic floor muscles by practising Kegel exercises (exercises that strengthen the muscles supporting your bladder and bowel) before surgery. This preparation can support continence recovery post-operatively.
- Maintain appropriate nutrition and hydration in the days before surgery while following specific fasting instructions for your anaesthesia type.
When to Seek Professional Help
- Progressive difficulty urinating despite medical therapy
- Recurrent urinary tract infections related to incomplete bladder emptying
- Bladder stones forming due to urinary stasis
- Kidney function deterioration from chronic obstruction
- Complete urinary retention requiring catheterisation
- Blood in urine persisting or recurring over several weeks
- Overflow incontinence from chronic urinary retention
- Previous prostate procedures with symptom recurrence
Commonly Asked Questions
How does robotic assistance improve the HoLEP procedure?
Robotic stabilisation eliminates hand tremor and fatigue. It provides consistent precision throughout the procedure. The enhanced visualisation and control particularly benefit the dissection near the sphincter (the muscle that controls urine flow) and apex (the bottom tip of the prostate). This may help reduce complications. The platform also enables better ergonomics for the surgeon during lengthy cases involving large prostates.
Will I need hormone therapy or additional treatments after Robotic HoLEP?
Robotic HoLEP treats benign enlargement (non-cancerous growth), not prostate cancer. The procedure doesn’t affect hormone production or require hormone therapy. If your surgeon finds cancer in the removed tissue, your urologist can discuss appropriate monitoring or treatment. This discussion may be based on the pathology findings (the laboratory analysis of the tissue) and your overall health status.
How soon can I resume sexual activity after surgery?
Patients can typically resume sexual activity after several weeks once they are comfortable and cleared by their surgeon. Erections and orgasm sensation remain unchanged. Ejaculation can be retrograde, meaning semen travels backwards into the bladder rather than out through the penis. Partners should understand this change doesn’t affect satisfaction or intimacy, only the physical absence of ejaculate.
What happens to the prostate tissue after removal?
All removed tissue undergoes pathological examination (laboratory analysis by a specialist doctor who examines tissue samples) to detect unexpected cancer. The pathologist examines multiple sections under microscopy. Results typically arrive within one to three weeks. Finding cancer doesn’t necessarily mean additional treatment. Your surgeon makes decisions based on cancer grade (how aggressive the cells appear), volume, and your overall health.
Can the prostate grow back after Robotic HoLEP?
The removed adenomatous tissue (the inner enlarged tissue) doesn’t regrow. The remaining peripheral zone (the outer shell of the prostate) stays but rarely causes obstruction. This explains the procedure’s low retreatment rates compared to other surgeries that remove less tissue.
Next Steps
Robotic HoLEP provides measurable symptom relief by completely removing the adenoma. The procedure offers low retreatment rates and preserves sexual function. Consider this option if medical therapy has failed to control your symptoms.
If you’re experiencing progressive difficulty urinating, recurrent infections, or urinary retention despite medical therapy, schedule a consultation with a urologist to determine if Robotic HoLEP is appropriate for your condition.
